Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice
Antonia Sassmann, Belinda Gier, Hermann-Josef Gröne, Gisela Drews, Stefan Offermanns, Nina Wettschureck
Antonia Sassmann, Belinda Gier, Hermann-Josef Gröne, Gisela Drews, Stefan Offermanns, Nina Wettschureck
View: Text | PDF
Research Article Metabolism

The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice

  • Text
  • PDF
Abstract

A variety of neurotransmitters, gastrointestinal hormones, and metabolic signals are known to potentiate insulin secretion through GPCRs. We show here that β cell–specific inactivation of the genes encoding the G protein α-subunits Gαq and Gα11 resulted in impaired glucose tolerance and insulin secretion in mice. Interestingly, the defects observed in Gαq/Gα11-deficient β cells were not restricted to loss of muscarinic or metabolic potentiation of insulin release; the response to glucose per se was also diminished. Electrophysiological recordings revealed that glucose-induced depolarization of isolated β cells was impaired in the absence of Gαq/Gα11, and closure of KATP channels was inhibited. We provide evidence that this reduced excitability was due to a loss of β cell–autonomous potentiation of insulin secretion through factors cosecreted with insulin. We identified as autocrine mediators involved in this process extracellular nucleotides such as uridine diphosphate acting through the Gq/G11-coupled P2Y6 receptor and extracellular calcium acting through the calcium-sensing receptor. Thus, the Gq/G11-mediated signaling pathway potentiates insulin secretion in response to glucose by integrating systemic as well as autocrine/paracrine mediators.

Authors

Antonia Sassmann, Belinda Gier, Hermann-Josef Gröne, Gisela Drews, Stefan Offermanns, Nina Wettschureck

×

Figure 5

Cosecreted factors potentiate insulin secretion in a Gαq/Gα11-dependent manner.

Options: View larger image (or click on image) Download as PowerPoint
Cosecreted factors potentiate insulin secretion in a Gαq/Gα11-dependent ...
(A) IP production in control (white) and Gαq/Gα11-deficient (black) islets in response to an increase in glucose from 2.8 mM to 16.7 mM (n = 4 independent experiments). (B) Intracellular calcium mobilization in control β cells elicited by 16.7 mM glucose, 50 μM OxoM, or 16.7 mM 2-deoxyglucose. The arrow indicates the time point of application; before application, cells were kept at 5 mM glucose. (C) Calcium mobilization in isolated Fura-2/AM–loaded control β cells in response to different mediators known to be released from glucose-stimulated β cells (ADP and ATP, 100 μM each; serotonin [5-HT], amylin, and prostaglandin E2 [PGE2], 1 μM each; UDP, 200 μM). (D) Calcium mobilization in isolated Fura-2/AM–loaded control and mutant β cells in response to the nucleotides UDP, ADP, and ATP. Data are presented as the 340/380 nm fluorescence ratio (Ratio F340/F380). (E) Stimulation of insulin secretion in control (white) and mutant (black) β cells in response to UDP and ADP (data expressed as x-fold of basal secretion) (n = 5–6 per group). (F) Insulin secretion of control islets in response to 16.7 mM glucose in the absence or presence of antagonists directed against different GPCR subtypes (data represent insulin concentration in the supernatant of 20 islets after 30 minutes of static incubation) (n = 4 independent experiments). *P ≤ 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts